In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent off the market. A senator launched an investigation to find out what happene… [+44 chars]
Source: CNN
Politics
Senate investigation: drugmaker harmed patients, profited, with asthma inhaler switch | CNN
In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent off the market. A senator launched an investigation to find out what happened, sharing her findings exclusively with CNN.
[ In-Article Advertisement Space ]
Related Stories
0 Comments
Sign in to join the conversation
No comments yet. Be the first!